
Multiomics is a new approach where the data sets of different omic groups are combined during analysis. The different omic strategies employed during multiomics are genome, proteome, transcriptome, epigenome, and microbiome.
The global Multiomics market size is projected to grow from US$ 2773 million in 2024 to US$ 5545 million in 2030; it is expected to grow at a CAGR of 12.2% from 2024 to 2030.
The “Multiomics Industry Forecast” looks at past sales and reviews total world Multiomics sales in 2022, providing a comprehensive analysis by region and market sector of projected Multiomics sales for 2023 through 2029. With Multiomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multiomics industry.
This Insight Report provides a comprehensive analysis of the global Multiomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Multiomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multiomics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multiomics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multiomics.
Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
This report presents a comprehensive overview, market shares, and growth opportunities of Multiomics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Single-cell Multiomics
Bulk Multiomics
Segmentation by Application:
Cell Biology
Oncology
Neurology
Immunology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Single-cell Multiomics
Bulk Multiomics
Segmentation by Application:
Cell Biology
Oncology
Neurology
Immunology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Thermo Fisher Scientific, Inc.
Illumina, Inc
Danaher (Beckman Coulter)
PerkinElmer, Inc
Shimadzu Corporation
Bruker
QIAGEN
Agilent Technologies, Inc.
BGI Genomics
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Multiomics Market Size 2019-2030
2.1.2 Multiomics Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Multiomics by Country/Region, 2019, 2023 & 2030
2.2 Multiomics Segment by Type
2.2.1 Single-cell Multiomics
2.2.2 Bulk Multiomics
2.3 Multiomics Market Size by Type
2.3.1 Multiomics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Multiomics Market Size Market Share by Type (2019-2024)
2.4 Multiomics Segment by Application
2.4.1 Cell Biology
2.4.2 Oncology
2.4.3 Neurology
2.4.4 Immunology
2.4.5 Others
2.5 Multiomics Market Size by Application
2.5.1 Multiomics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Multiomics Market Size Market Share by Application (2019-2024)
3 Multiomics Market Size by Player
3.1 Multiomics Market Size Market Share by Player
3.1.1 Global Multiomics Revenue by Player (2019-2024)
3.1.2 Global Multiomics Revenue Market Share by Player (2019-2024)
3.2 Global Multiomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Multiomics by Region
4.1 Multiomics Market Size by Region (2019-2024)
4.2 Global Multiomics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Multiomics Market Size Growth (2019-2024)
4.4 APAC Multiomics Market Size Growth (2019-2024)
4.5 Europe Multiomics Market Size Growth (2019-2024)
4.6 Middle East & Africa Multiomics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Multiomics Market Size by Country (2019-2024)
5.2 Americas Multiomics Market Size by Type (2019-2024)
5.3 Americas Multiomics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Multiomics Market Size by Region (2019-2024)
6.2 APAC Multiomics Market Size by Type (2019-2024)
6.3 APAC Multiomics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Multiomics Market Size by Country (2019-2024)
7.2 Europe Multiomics Market Size by Type (2019-2024)
7.3 Europe Multiomics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Multiomics by Region (2019-2024)
8.2 Middle East & Africa Multiomics Market Size by Type (2019-2024)
8.3 Middle East & Africa Multiomics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Multiomics Market Forecast
10.1 Global Multiomics Forecast by Region (2025-2030)
10.1.1 Global Multiomics Forecast by Region (2025-2030)
10.1.2 Americas Multiomics Forecast
10.1.3 APAC Multiomics Forecast
10.1.4 Europe Multiomics Forecast
10.1.5 Middle East & Africa Multiomics Forecast
10.2 Americas Multiomics Forecast by Country (2025-2030)
10.2.1 United States Market Multiomics Forecast
10.2.2 Canada Market Multiomics Forecast
10.2.3 Mexico Market Multiomics Forecast
10.2.4 Brazil Market Multiomics Forecast
10.3 APAC Multiomics Forecast by Region (2025-2030)
10.3.1 China Multiomics Market Forecast
10.3.2 Japan Market Multiomics Forecast
10.3.3 Korea Market Multiomics Forecast
10.3.4 Southeast Asia Market Multiomics Forecast
10.3.5 India Market Multiomics Forecast
10.3.6 Australia Market Multiomics Forecast
10.4 Europe Multiomics Forecast by Country (2025-2030)
10.4.1 Germany Market Multiomics Forecast
10.4.2 France Market Multiomics Forecast
10.4.3 UK Market Multiomics Forecast
10.4.4 Italy Market Multiomics Forecast
10.4.5 Russia Market Multiomics Forecast
10.5 Middle East & Africa Multiomics Forecast by Region (2025-2030)
10.5.1 Egypt Market Multiomics Forecast
10.5.2 South Africa Market Multiomics Forecast
10.5.3 Israel Market Multiomics Forecast
10.5.4 Turkey Market Multiomics Forecast
10.6 Global Multiomics Forecast by Type (2025-2030)
10.7 Global Multiomics Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Multiomics Forecast
11 Key Players Analysis
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Multiomics Product Offered
11.1.3 BD Multiomics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Information
11.2.2 Thermo Fisher Scientific, Inc. Multiomics Product Offered
11.2.3 Thermo Fisher Scientific, Inc. Multiomics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific, Inc. Latest Developments
11.3 Illumina, Inc
11.3.1 Illumina, Inc Company Information
11.3.2 Illumina, Inc Multiomics Product Offered
11.3.3 Illumina, Inc Multiomics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina, Inc Main Business Overview
11.3.5 Illumina, Inc Latest Developments
11.4 Danaher (Beckman Coulter)
11.4.1 Danaher (Beckman Coulter) Company Information
11.4.2 Danaher (Beckman Coulter) Multiomics Product Offered
11.4.3 Danaher (Beckman Coulter) Multiomics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Danaher (Beckman Coulter) Main Business Overview
11.4.5 Danaher (Beckman Coulter) Latest Developments
11.5 PerkinElmer, Inc
11.5.1 PerkinElmer, Inc Company Information
11.5.2 PerkinElmer, Inc Multiomics Product Offered
11.5.3 PerkinElmer, Inc Multiomics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 PerkinElmer, Inc Main Business Overview
11.5.5 PerkinElmer, Inc Latest Developments
11.6 Shimadzu Corporation
11.6.1 Shimadzu Corporation Company Information
11.6.2 Shimadzu Corporation Multiomics Product Offered
11.6.3 Shimadzu Corporation Multiomics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Shimadzu Corporation Main Business Overview
11.6.5 Shimadzu Corporation Latest Developments
11.7 Bruker
11.7.1 Bruker Company Information
11.7.2 Bruker Multiomics Product Offered
11.7.3 Bruker Multiomics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bruker Main Business Overview
11.7.5 Bruker Latest Developments
11.8 QIAGEN
11.8.1 QIAGEN Company Information
11.8.2 QIAGEN Multiomics Product Offered
11.8.3 QIAGEN Multiomics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 QIAGEN Main Business Overview
11.8.5 QIAGEN Latest Developments
11.9 Agilent Technologies, Inc.
11.9.1 Agilent Technologies, Inc. Company Information
11.9.2 Agilent Technologies, Inc. Multiomics Product Offered
11.9.3 Agilent Technologies, Inc. Multiomics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Agilent Technologies, Inc. Main Business Overview
11.9.5 Agilent Technologies, Inc. Latest Developments
11.10 BGI Genomics
11.10.1 BGI Genomics Company Information
11.10.2 BGI Genomics Multiomics Product Offered
11.10.3 BGI Genomics Multiomics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BGI Genomics Main Business Overview
11.10.5 BGI Genomics Latest Developments
12 Research Findings and Conclusion
*If Applicable.
